Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Antonella Cusimano
Preclinical Evaluation of Antitumor Activity of the Proteasome Inhibitor MLN2238 (Ixazomib) in Hepatocellular Carcinoma Cells
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Related publications
Preclinical Evaluation of Biomarkers Associated With Antitumor Activity of MELK Inhibitor
Oncotarget
Oncology
Preclinical Antitumor Activity of SST0116CL1: A Novel Heat Shock Protein 90 Inhibitor
International Journal of Oncology
Cancer Research
Oncology
Phase 1 Study of Ixazomib, an Investigational Proteasome Inhibitor, in Advanced Non-Hematologic Malignancies
Investigational New Drugs
Oncology
Pharmacology
Triclosan Treatment Decreased the Antitumor Effect of Sorafenib on Hepatocellular Carcinoma Cells
OncoTargets and Therapy
Oncology
Pharmacology
Antitumor Activity of the Polo-Like Kinase Inhibitor, TAK-960, Against Preclinical Models of Colorectal Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Capsaicin Enhances the Antitumor Activity of Sorafenib in Hepatocellular Carcinoma Cells and Mouse Xenograft Tumors Through Increased ERK Signaling
Acta Pharmacologica Sinica
Medicine
Pharmacology
Antitumor Effect of Sorafenib and mTOR Inhibitor in Liver Transplantation Recipients With Hepatocellular Carcinoma Recurrence
Liver Transplantation
Hepatology
Transplantation
Surgery
The Combination of MLN2238 (Ixazomib) With Interferon-Alpha Results in Enhanced Cell Death in Melanoma
Oncotarget
Oncology
In�vivo Antitumor Activity Evaluation of Cancer Vaccines Prepared by Various Antigen Forms in a Murine Hepatocellular Carcinoma Model
Oncology Letters
Cancer Research
Oncology